Evidence map›Paper›PMID 34151740›Full record

Observational studyEmerging microbes & infections2021

Catherine Hyams, Zahin Amin-Chowdhury, Norman K Fry, Paul North, Adam Finn, Andrew Judge, Shamez N Ladhani, O Martin Williams

Open access · goldAbstract readObservational Study
In one paragraph

Observational study in Emerging microbes & infections, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.2field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Parapneumonic effusions related toBMJ open respiratory research · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 1 country.

Catherine HyamsAcademic Respiratory Unit, Learning and Research Building, Southmead Hospital, Bristol, UK.ORCID https://orcid.org/0000-0003-3923-1773
Zahin Amin-ChowdhuryNational Infection Service, Public Health England, London, UK.ORCID https://orcid.org/0000-0002-1772-2734
Norman K FryNational Infection Service, Public Health England, London, UK.ORCID https://orcid.org/0000-0003-4862-6507
Paul NorthMicrobiology Services Bristol, Bristol Royal Infirmary, Bristol, UK.
Adam FinnBristol Children's Vaccine Centre, Schools of Cellular and Molecular Medicine and of Population Health Sciences, University of Bristol, Bristol, UK.ORCID https://orcid.org/0000-0003-1756-5668
Andrew JudgeMusculoskeletal Research Unit, University of Bristol, Bristol, UK.ORCID https://orcid.org/0000-0003-3015-0432
Shamez N LadhaniNational Infection Service, Public Health England, London, UK.ORCID https://orcid.org/0000-0002-0856-2476
O Martin WilliamsMicrobiology Services Bristol, Bristol Royal Infirmary, Bristol, UK.
Public Health England · GBUniversity Hospitals Bristol NHS Foundation Trust · GBUniversity of Bristol · GBSouthmead Hospital · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Few studies on adult pneumococcal septic arthritis are sufficiently large enough to assess both epidemiological trends following routine pneumococcal immunization and clinical disease. With major shifts in serotypes causing invasive pneumococcal disease (IPD), we wanted to determine the clinical phenotype of adult septic arthritis caused by

Indexed as

AdultAgedAged, 80 and overArthritis, InfectiousComorbidityFemaleHumansMaleMiddle AgedPneumococcal InfectionsRetrospective StudiesRisk FactorsSerogroupStreptococcus pneumoniaeTreatment OutcomeUnited Kingdominvasive pneumococcal diseasePCV-13pneumococcal vaccinesPneumococcusseptic arthritisStreptococcus pneumoniae

Identifiers

PMID34151740
PMCPMC8259820
OpenAlexW3175309131

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.